Food and Drug Administration (FDA) has released a new draft guidance for industry #290 (VICH GL61), Pharmaceutical Development. Developed for veterinary use, the draft guidance discusses the suggested contents for the Pharmaceutical Development section that is intended to help reviewers and investigators of animal drug products understand the product, as well as the manufacturing process of these drugs. FDA is encouraging individuals to submit comments on the draft guidance within 60 days to ensure that the comments are considered before the agency begins drafting the final version of the guidance document.